
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
CORONA VIRUS DISEASE 2019 (COVID-19): A REVIEW
Bhagyashri B. Sakhare*, Nandkishor B. Bavage, Shyamlila B. Bavage, Gali Vidyasagar
Abstract COVID-19 has spread through out to most countries in the world. The impact of the corona virus disease is different in different countries. These differences are assigned to differences in all cultural norms mitigation efforts and health infrastructure. Coronavirus disease (COVID-19), which appeared in December 2019, presents a global challenge, particularly in the rapid increase of critically ill patients with pneumonia and absence of definitive treatment. The mortality appears to be around 2%; early published data indicate 25.9% with SARS-CoV-2 pneumonia required ICU admission and 20.1% developed acute respiratory distress syndrome. There is presently no vaccine or specific anti-viral drug regime used to treat critically ill patients. The management of patients mainly focuses on the provision of supportive care, e.g., oxygenation, ventilation, and fluid management. Combination treatment of low-dose systematic corticosteroids and anti-virals and atomization inhalation of interferon have been encouraged as part of critical COVID-19 management. This paper aggregates and consolidates the epidemiology, clinical manifestations, diagnosis, treatments and prevention of this new type of coronavirus. The impact of this new epidemic globally is yet uncertain. Keywords: Coronavirus, SARS-CoV-2, 2019-nCOV, Treatment, Review. [Full Text Article] [Download Certificate] |
